All Cancer articles – Page 5
-
NewsAction on white asbestos blocked by top exporters
Chrysotile will not be added to Rotterdam Convention’s list of hazardous substances
-
Business
Expanding precision medicine beyond cancer
Exclusive interview with Koustubh Ranade, vice president of R&D at MedImmune
-
News
Glyphosate is not carcinogenic, EU chemicals association concludes
Evaluation clears the way for long term authorisation of herbicide
-
-
Business
University–industry collaborations aspire to pharmaceutical innovation
Three new UK partnerships illustrate drug research co-operation approaches that are growing in popularity
-
Research
Personalised medicine boost as cancer drug monitored in real-time
Aptamer-based sensors can track levels of small molecules in rats as the go about their business
-
Business
Ipsen to buy Merrimack’s cancer drugs
$1bn deal covers two liposome-encapsulated formulations of approved therapies
-
Business
Takeda to buy cancer specialist Ariad
Japan’s largest drug company agrees $5.2bn deal to expand oncology portfolio and boost pipeline
-
News
Fears that gene-editing cancer trials are premature
Warnings from geneticists that Crispr trial failures could knock promising technique’s prospects
-
Business
DuPont found liable in third bellwether cancer case
US court orders firm to pay $2m in damages to man whose disease has been linked to contaminated water supply
-
Podcast
Bromodeoxyuridine
Kat Arney illuminates the story of a molecular ‘highlighter pen’ for growing cells
-
News
WHO cancer agency criticised for outdated chemical risk methods
Criticism of carcinogenicity assessments that place processed meat in the same category as mustard gas
-
Podcast
PARP: Poly (ADP-ribose) polymerase
Kat Arney explains how a protein that repairs broken DNA holds the key to killing cancer cells – but only if you stop it from doing its job
-
-
Research
Connectosomes smuggle drugs across membranes
Engineered vesicles could cut drug side-effects by delivering them straight into cells using cellular ‘airlocks’
-
Podcast
Fluorouracil
A substitute for one of the bases in DNA that can cause the death of cancer cells
-
Research
Tumour cells' last breaths dampen down immune system
Dying cancer cells release potassium ions that alter the behaviour of T-cells
-
Research
Nanoplasters get cells into sticky situation
Nanoparticles that glue cells together could aid wound healing or stop tumour metastasis
-
Business
Novartis reshuffle puts 120 staff at risk
Commitment to gene and cell therapy treatments emphasised as unit broken up amid pharmaceutical division refocus
-
Business
Pfizer gambles on $14bn Medivation deal
Cancer specialist likely just one target in hunt for marketed drugs to offset patent expiries
